Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Assets Average (2016 - 2020)

Historic Assets Average for Larimar Therapeutics (LRMR) over the last 7 years, with Q3 2020 value amounting to $119.7 million.

  • Larimar Therapeutics' Assets Average rose 2167.14% to $119.7 million in Q3 2020 from the same period last year, while for Sep 2020 it was $119.7 million, marking a year-over-year increase of 2167.14%. This contributed to the annual value of $63.5 million for FY2019, which is 4413.61% down from last year.
  • Larimar Therapeutics' Assets Average amounted to $119.7 million in Q3 2020, which was up 2167.14% from $99.6 million recorded in Q2 2020.
  • In the past 5 years, Larimar Therapeutics' Assets Average ranged from a high of $179.6 million in Q1 2016 and a low of $39.5 million during Q1 2020
  • For the 5-year period, Larimar Therapeutics' Assets Average averaged around $111.5 million, with its median value being $107.0 million (2019).
  • In the last 5 years, Larimar Therapeutics' Assets Average surged by 2573.82% in 2018 and then crashed by 6598.23% in 2020.
  • Over the past 5 years, Larimar Therapeutics' Assets Average (Quarter) stood at $137.2 million in 2016, then fell by 26.45% to $100.9 million in 2017, then grew by 25.74% to $126.9 million in 2018, then plummeted by 61.34% to $49.0 million in 2019, then soared by 144.08% to $119.7 million in 2020.
  • Its Assets Average stands at $119.7 million for Q3 2020, versus $99.6 million for Q2 2020 and $39.5 million for Q1 2020.